[1]彭程,赵明光.颅后窝减压+硬脑膜劈裂术与颅后窝减压+硬脑膜成形术治疗Chiari畸形Ⅰ型的疗效对比分析[J].中国临床神经外科杂志,2023,28(07):417-420.[doi:10.13798/j.issn.1009-153X.2023.07.001]
　PENG Cheng,ZHAO Ming-guang.Clinical efficacy of surgery for patients with Chiari malformation type Ⅰ: posterior fossa decompression with duraplasty versus posterior fossa decompression with dural splitting[J].,2023,28(07):417-420.[doi:10.13798/j.issn.1009-153X.2023.07.001]
点击复制

颅后窝减压+硬脑膜劈裂术与颅后窝减压+硬脑膜成形术治疗Chiari畸形Ⅰ型的疗效对比分析()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年07期
页码:
417-420
栏目:
论著
出版日期:
2023-07-31

文章信息/Info

Title:
Clinical efficacy of surgery for patients with Chiari malformation type Ⅰ: posterior fossa decompression with duraplasty versus posterior fossa decompression with dural splitting
文章编号:
1009-153X（2023）07-0417-04
作者:
彭程; 赵明光
110016沈阳，北部战区总医院神经外科（彭程、赵明光）；110092沈阳，北部战区空军医院神经外科（彭程）
Author(s):
PENG Cheng1; 2;  ZHAO Ming-guang1
1. Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang 110016, China; 2. Department of Neurosurgery, The Air Force Hospital of Northern Theater Command, Shenyang 110092, China
关键词:
Chiari畸形Ⅰ型; 颅后窝减压术; 硬脑膜劈裂术; 硬脑膜成形术; 疗效
Keywords:
ChiariⅠmalformation;  Posterior fossa decompression;  Dural splitting;  Duraplasty;  Clinical efficacy
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2023.07.001
文献标志码:
R742.8;R651.1+1
摘要:
目的 对比分析颅后窝减压+硬脑膜劈裂术（PFDDS）与颅后窝减压+硬脑膜成形术（PFDD）治疗Chiari畸形Ⅰ型（CM-Ⅰ）的临床疗效。方法 回顾性分析2017年10月~2023年10月手术治疗的197例CM-Ⅰ的临床资料。113例采用PFDD治疗，84例采用PFDDS治疗。术后6个月依据芝加哥Chiari畸形预后量表（CCOS）评分评估疗效，其中13~16分为预后良好；根据MRI复查结果评估脊髓空洞改善情况。结果 术后6个月，PFDDS组和PFDD组预后良好率分别为57.1%、54.9%，脊髓空洞改善率分别为78.5%、72.4%；两组预后良好率和脊髓空洞改善率均无统计学差异（P>0.05）。与PFDD组相比，PFDDS组手术时间和术中出血量明显减少（P<0.05）、术后住院时间明显缩短（P<0.05）。两组术后并发症发生率无统计学差异（P>0.05）。结论 PFDDS和PFDD治疗CM-Ⅰ的临床效果确切，但PFDDS可减少手术时间、术中出血量，缩短住院时间。
Abstract:
Objective To compare the clinical efficacy of posterior fossa decompression with duraplasty (PFDD) and posterior fossa decompression with dural splitting (PFDD) for patients with Chiari malformation type Ⅰ (CM-Ⅰ). Methods The clinical data of 197 patients with CM-Ⅰwho were treated with operation from October 2017 to October 2023 were retrospectively analyzed. One hundren and thirteen patients were treated with PFDD, and 84 patients were treated with PFDDS. The efficacy was evaluated by the Chicago Chiari outcome scale (CCOS) score at 6 months after the surgery, with a score of 13~16 as a good prognosis. The improvement of syringomyelia was evaluated according to the MRI at 6 months after the surgery. Results The good prognosis rates were 57.1% and 54.9%and the improvement rates of syringomyelia were 78.5% and 72.4% of PFDDS and PFDD groups, respectively. There were no significant differences in the rates of good prognosis and syringomyelia improvement between both groups (P>0.05). The operative time and the intraoperative blood loss in PFDDS group were significantly lower than those in PFDD group (P<0.05). The length of postoperative hospital stay in PFDDS group was significantly shorter than that in PFDD group (P<0.05). There were no significant difference in the incidence of postoperative complications between both groups (P>0.05). Conclusions PFDDS and PFDD are effective in the treatment of patients with CM-Ⅰ, but PFDDS can reduce operative time and intraoperative blood loss, and shorten the length of postoperative hospital stay.

参考文献/References:

[1]常腾武，王继超. Chiari畸形Ⅰ型的诊治现状[J]. 中国临床神经外科杂志，2021，26（7）：564-566.
[2]王　鑫，李永宁，高　俊，等. 芝加哥Chiari畸形预后量表在Ⅰ型Chiari畸形合并脊髓空洞手术疗效评估中的价值[J]. 中国临床神经外科杂志，2019，24（9）：554-556.
[3]王乙锠，张　妙，何百祥. Chiari畸形的研究进展[J]. 西安交通大学学报（医学版），2021，42（4）：491-496.
[4]Goel A. A review of a new clinical entity of 'central atlantoaxial instability': expanding horizons of craniovertebral junction surgery [J]. Neurospine, 2019, 16(2): 186-194.
[5]何运森，郑　涛，张孙鑫，等. Chiari畸形Ⅰ型合并脊髓空洞症的诊疗进展[J]. 中国临床神经外科杂志，2019，24（1）：55-58.
[6]Oklfied EH, Muraszko K, Shawker TH, et al. Pathophysiology of syringomyelia associatied with Chiari 1 malfomation of the cerebellar tonsils implication for diagnosis and treatment [J]. J Neurosurg, 1994, 80(1): 3-15.
[7]Isu T, Sasaki H, Takamura H, et al. Foramen magnum decompression with removal of the outer layer of the dura as treatment for syringomyelia occurring with Chiari I malformation [J]. Neurosurgery, 1993, 33(5): 845-850.
[8]Chai Z, Xue X, Fan H, et al. Efficacy of posterior fossa decompression with duraplasty for patients with Chiari malformation type I: a systematic review and meta-analysis [J]. World Neurosurg, 2018, 113: 357-365.
[9]Chauvet D, Carpentier A, Allain JM, et al. Histological and biomechanical study of dura mater applied to the technique of dura splitting decompression in Chiari type I malformation [J]. Neurosurg Rev, 2010, 33(3): 287-295.
[10]Pandey S, Li L, Wan RH, et al. A retrospective study on outcomes following posterior fossa decompression with dural splitting surgery in patients with Chiari type I malformation [J]. Clin Neurol Neurosurg, 2020, 196: 106035.
[11]Chotai S, Medhkour A. Surgical outcomes after posterior fossa decompression with and without duraplasty in Chiari malformation-I [J]. Clin Neurol Neurosurg, 2014, 125: 182-188.
[12]Chen J, Li Y, Wang T, et al. Comparison of posterior fossa decompression with and without duraplasty for the surgical treatment of Chiari malformation type I in adult patients: a retrospective analysis of 103 patients [J]. Medicine, 2017, 96(4): 45-59.
[13]Oral S, Yilmaz A, Kucuk A, et al. Comparison of dural splitting and duraplasty in patients with Chiari type I malformation: relationship between tonsillo-dural distance and syrinx cavity [J]. Turk Neurosurg, 2019, 29(2): 229-236.
[14]Arslan A, Olguner SK, Acik V, et al. Surgical outcomes of C1-2 posterior stabilization in patients with Chiari malformation type 1 [J]. Global Spine J, 2022, 12(1): 37-44.
[15]康宏达，卢二勤，宋　凯，等. Chiari畸形术后寰枕交界区稳定性的临床观察[J]. 中国临床神经外科杂志，2018，23（3）：204-205.
[16]Xu H, Chu L, He R, et al. Posterior fossa decompression with and without duraplasty for the treatment of Chiari malformation type I--a systematic review and meta-analysis [J]. Neurosurg Rev, 2017, 40(2): 213-221.

相似文献/References:

[1]张家康　彭　飞　陈　鑫　侯　旭　张大明　刘震东　赵世光.后颅窝减压术治疗Chiari畸形Ⅰ型合并脑积水疗效的Meta分析[J].中国临床神经外科杂志,2016,(03):158.[doi:10.13798/j.issn.1009-153X.2016.03.009]
　ZHANG Jia-kang,PENG Fei,CHEN Xin,et al.Posterion fossa decompression for Chiari I malformation with hydrocephalus: a meta-analysis[J].,2016,(07):158.[doi:10.13798/j.issn.1009-153X.2016.03.009]
[2]高　竑　杨　华　向　欣.Chiari畸形Ⅰ型合并脊髓空洞症的显微手术治疗[J].中国临床神经外科杂志,2018,(02):75.
　GAO Hong,YANG Hua,XIANG Xin..Curative effects of two surgical methods on Chiari Malformation type Ⅰ complicated with syringomyelia[J].,2018,(07):75.
[3]黄建睿　卢培刚　钟启胜　王衍廷　赵振宇.保留枕骨大孔的颅后窝减压术治疗Ⅰ型小脑扁桃体下疝畸形的疗效[J].中国临床神经外科杂志,2020,(02):79.[doi:10.13798/j.issn.1009-153X.2020.02.006]
　HUANG Jian-rui,LU Pei-gang,ZHONG Qi-sheng,et al.Posterior fossa decompression with preservation of intact occipital foramen for Chiari malformation-Ⅰ[J].,2020,(07):79.[doi:10.13798/j.issn.1009-153X.2020.02.006]
[4]殷　杰　王启弘.Chiari 畸形颅后窝减压术后并发脑脊液漏1例[J].中国临床神经外科杂志,2021,26(04):232.[doi:10.13798/j.issn.1009-153X.2021.04.003]

备注/Memo

备注/Memo:
（2023-03-25收稿，2023-05-19修回）
通讯作者：赵明光，E-mail：mingguangzhao1970@126.com
更新日期/Last Update: 2022-07-31